Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03609047
Title Adjuvant Palbociclib in Elderly Patients With Breast Cancer (Appalaches)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications

Her2-receptor negative breast cancer

Therapies

Palbociclib

Cyclophosphamide + Epirubicin

Paclitaxel

Cyclophosphamide + Docetaxel

Cyclophosphamide + Doxorubicin

Age Groups: senior
Covered Countries ITA | FRA | ESP | DEU | BEL


No variant requirements are available.